Anthera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

ANTH 5.20 +0.31 (6.34%)
price chart
Drowning Stocks Update - Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...
On Monday, Following U.S. Stocks were among the �Top Losers�: Anthera Pharmaceuticals Inc (NASDAQ:ANTH), NTELOS Holdings Corp (NASDAQ:NTLS), Axion Power International, Inc. (NASDAQ:AXPW), Seventy Seven Energy Inc (NYSE:SSE).
Update: Short Interest of Anthera Pharmaceuticals, Inc. Drops by -2.4%
Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH) reported a drop of 2.4% or 37,047 shares in its short interest. The short figure came in at 7.3% of the total floats.
Anthera Pharmaceuticals Announces Completion of Interim Analysis from Phase ...
HAYWARD, Calif., March 16, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. ANTH, -1.42% in collaboration with its partner Zenyaku Kogyo Co.
Anthera Pharmaceuticals's Buy Rating Reaffirmed at Jefferies Group (ANTH)  The Legacy
Worth-Watching U.S. Stocks Alert: Anthera Pharmaceuticals Inc (NASDAQ:ANTH ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH)'s shares picked up 10.67%, and closed at $6.12, hitting new 52-week high of $6.36.
Gigantic Turns Alert - Insmed Incorporated (NASDAQ:INSM), Anthera ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH), raised 6.96%, and closed at $5.53, hitting new 52-week high of $5.61. The stock has the beta value of 1.77, and its volatility for the week is 7.55%, while for the month it is 11.07%.
PowerSecure International Inc. (POWR), Anthera Pharmaceuticals Inc (ANTH ...
Last Friday, Kevin Kotler's Broadfin Capital disclosed a marked increase (of almost 70%) in its exposure to Anthera Pharmaceuticals Inc (NASDAQ:ANTH). According to a Schedule 13G filed with the Securities and Exchange Commission, the fund now owns ...
Analysis On Gaining Stocks: MannKind Corporation (NASDAQ:MNKD), Anthera ...
Anthera Pharmaceuticals Inc (NASDAQ:ANTH), raised 4.99%, and closed at $5.47. The stock has the beta value of 1.77, and its volatility for the week is 14.72%, while for the month it is 13.06%.
Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
HAYWARD, Calif., March 18, 2015 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH) today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock, offered at a price of $4.50 per share.
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock  MarketWatch
Top Stories: Recro Pharma, Inc. (NASDAQ:REPH), Anthera Pharmaceuticals, Inc ...
Recro Pharma, Inc. (NASDAQ:REPH) belongs to Healthcare sector. Its weekly performance is -11.01%. On last trading day company shares ended up $11.88. Recro Pharma, Inc. (NASDAQ:REPH) distance from 50-day simple moving average (SMA50) is ...
Anthera jumps as interest in lupus med builds (ANTH)
Thinly-traded nano cap Anthera Pharmaceuticals (ANTH +32.6%) jumps on a bullish 16x surge in volume. The company has a symposium on systemic lupus erythematosus scheduled for next week in San Francisco.